申请人:Institute of Medicinal Molecular Design, Inc.
公开号:EP2080751A1
公开(公告)日:2009-07-22
A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1):
wherein R1 represents a C6-10 aryl group; or a substituted C6-10 aryl group, R2 represents a C6-10 aryl group; or a C6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, nitro group, a C1-6 alkyl group, a halogenated C1-6 alkyl group, a C1-6 alkoxy group, a halogenated C1-6 alkoxy group, a phenyl group and carboxy group, X represents -CH2-, -CH2CH2-, -CH=CH- or -N(R3)-C(=O)-, Y represents carboxy group or a bioisostere of carboxy group, R3 represents hydrogen atom, a C1-4 alkyl group or a C7-12 aralkyl group, m represents 0 or 1.
由下式通式(I)代表的化合物或其盐或其水合物或其溶液,对纤溶酶原激活物抑制剂-1(PAI-1)具有抑制作用:
其中 R1 代表 C6-10 芳基;或取代的 C6-10 芳基,R2 代表 C6-10 芳基;或被一个或多个基团取代的 C6-10 芳基,这些基团选自由卤素原子、硝基、C1-6 烷基、卤代 C1-6 烷基、C1-6 烷氧基、卤代 C1-6 烷氧基组成的组、X代表-CH2-、-CH2CH2-、-CH=CH-或-N(R3)-C(=O)-,Y代表羧基或羧基的生物异构体,R3代表氢原子、C1-4 烷基或 C7-12 芳基,m 代表 0 或 1。